SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-134821
Filing Date
2018-04-26
Accepted
2018-04-26 16:16:02
Documents
6
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d562018ddefa14a.htm DEFA14A 36153
2 GRAPHIC g562018g25e88.jpg GRAPHIC 1831
3 GRAPHIC g562018g39b87.jpg GRAPHIC 1828
4 GRAPHIC g562018g49q42.jpg GRAPHIC 1828
5 GRAPHIC g562018g81f41.jpg GRAPHIC 1824
6 GRAPHIC g562018notarrow.jpg GRAPHIC 2830
  Complete submission text file 0001193125-18-134821.txt   51931
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36279 | Film No.: 18778747
SIC: 2834 Pharmaceutical Preparations